FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot
by Marco Cáceres
An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and ...
Protestors Target Kellogg’s Over Cereal Dyes
by Natasha Hobley
It has been nearly a decade since the cereal brand giant Kellogg’s announced that it would remove artificial colors and ...
Nearly 50 Percent of Federal Panelists Making Dietary Recommendations Have Money Ties to Food Industry
by Natasha Hobley
About half of the members of a U.S. federal government panel that shapes dietary recommendations in the United States have ...
Private Equity Buyouts of Health Care Facilities Comes With Cost to Patients
by Natasha Hobley
The rising trend in burnout of health care workers in recent years has presented an opportunity for private equity corporations ...
EcoHealth Alliance Sued by Families for Funding Chinese Institute Linked to Mutant SARS-CoV-2
by Carolyn Hendler, JD
Family members of four people who died from COVID-19 are suing the New York-based non-profit EcoHealth Alliance and its president, ...
Phillips Ventilators and BiPAP and CPAP and Breathing Machines Recalled Due to Health Risks
by Rishma Parpia
On Aug. 16, 2022 the U.S. Food and Drug Administration (FDA) issued an update on a June 2021 recall of ...
COVID Shot Requirements in Employment Ads are Decreasing
by Rishma Parpia
A new analysis conducted by AnnElizabeth Konkel, an economist at the Indeed Hiring Lab in Austin, Texas, shows that the ...
Baby Formula Industry Slammed for Manipulative Social Media Marketing
by Natasha Hobley
In 1981, the World Health Assembly released a public health strategy known as The International Code of Marketing of Breast-Milk Substitutes ...
The Cautionary Tale of a Biotech Company’s Founder, Convicted of Fraud
by Natasha Hobley
Elizabeth Holmes was once seen as a revolutionary female genius who graced the cover of magazines such as Forbes and ...
In this section
Latest
Popular
Comments
Latest
Popular
Comments
- on FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
- on FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
- on Merck Settles Gardasil Vaccine Injury Lawsuit for $50 Million
- on Study Finds Ivermectin and Mebendazole Beneficial in Treating Cancer
- on The Debate Over ADHD and Doctor Prescribed Video Games
